An IVF cycle is not a visit. It is a protocol that runs for weeks: baseline scan, stimulation, a string of follicular-monitoring ultrasounds, trigger, retrieval, the embryology lab, transfer, then the wait. Generic clinic software was built for the single consult, so it has nowhere clean to hold a stimulation chart, a witnessing log, or a straw sitting in a tank. That gap is the whole reason fertility-specific software exists. This guide walks through what an ART clinic in India actually needs, the ART Act 2021 record-keeping layer that sits on top of clinical care, what prices look like, the DPDP duties that come with reproductive data, and where an AI documentation layer fits without pretending to be your embryology system.
Key takeaways
- A fertility cycle is longitudinal, so the software has to track stimulation and follicular monitoring day by day, hold embryology lab records, and trace donor and gamete material. Generic clinic tools model none of this.
- The ART Act 2021 makes cycle, donor, and outcome record-keeping a legal duty, with registration and reporting to the National ART and Surrogacy Registry (India Code). Your software has to produce those records on demand.
- Reproductive data is among the most sensitive a clinic holds. Under the DPDP Act 2023 you are the data fiduciary, so purpose and storage limits are legal, not optional (MeitY).
- An AI documentation layer drafts the consult note for the clinician to review and sign. It does not do embryology witnessing, cryo-inventory, or registry reporting. Those stay in your specialist systems.
Year the ART (Regulation) Act took effect, mandating clinic registration and cycle record-keeping (India Code)
Fertility-specific record domains generic clinic software does not model: stimulation, embryology, donor traceability, statutory consent
GST added to software subscriptions in India, on top of the ex-GST price
Sources: The ART (Regulation) Act, 2021 (India Code); MeitY, DPDP Act 2023.
If your practice management already works and the drain is the note you type after every consult, you can skip ahead and book a short demo to see where a documentation layer lands. If you are choosing the core system, start with what fertility work demands.
What does an IVF clinic actually need from software?
Set the brochure aside. A fertility practice needs the same booking-and-billing spine any clinic does, plus four things that are specific to assisted reproduction. Miss those four and you end up running the real work in spreadsheets beside the software you paid for.
- Stimulation and follicular-monitoring tracking. A cycle is a dated protocol. Gonadotropin doses change across days, and each monitoring scan records follicle counts and sizes and endometrial thickness. The software has to hold that as a timeline you can read at a glance, not as loose notes scattered across separate visit records.
- Embryology lab records. This is the domain generic tools have no home for. Fertilization method, day-3 and day-5 grading, witnessing steps at each handling point, and cryo-storage inventory that tells you which straw sits in which tank and cane. Losing track of a frozen embryo is not a data-entry slip; it is a clinical and legal event.
- Donor, recipient, and gamete traceability. Where third-party gametes are used, the chain from donor to recipient to outcome has to be recorded and auditable. The ART Act 2021 leans hard on this, and the software has to make the link, not leave it to memory.
- Consent and statutory record-keeping. ART involves multiple distinct consents across the cycle, and the ART Act 2021 requires the clinic to hold and produce records for the National Registry. The tool has to store the right consents against the right cycle and export what the registry expects.
Package and cost estimation matters too, because an IVF cycle is a large, itemised bill, and patients ask for a number before they commit. GST-compliant billing that ties line items back to the cycle is table stakes. Everything past these is a tie-breaker, so decide which of the four you cannot fake in a spreadsheet, then judge tools on those.
ART software and generic clinic software diverge on two axes
Two things separate software built for fertility from software that merely tolerates it, and they map to the two halves of an IVF clinic: the clinic side and the lab side.
On the clinic side, it is the cycle timeline. A general OPD tool treats today’s visit as a self-contained consult, so a stimulation protocol becomes a pile of disconnected notes. ART software makes the cycle the unit of work, the way a good dental tool makes the tooth the unit of work. You open one cycle and see the whole arc: baseline, every monitoring scan, the trigger, the retrieval count. For a broader view of how India-native systems compare on the clinic side, our EMR software guide and the clinic management software scorecard are useful reading.
On the lab side, it is the embryology record and cryo-inventory. This is not a module you can approximate. Witnessing (the second-person verification at each handling step that guards against mix-ups) has to be logged, and cryo-storage has to know physical location down to the tank. A generic clinic tool’s inventory feature was designed for pharmacy stock; it has no concept of a straw or a witnessing signature. When you evaluate a “fertility module” bolted onto general software, this is the first thing to stress-test.
| Capability | Capability | ART / IVF-specific software | Generic clinic tool with fertility bolt-on | AI documentation layer (sits on top) |
|---|---|---|---|---|
| Stimulation + follicular-monitoring timeline | Core, cycle-based | Often loose visit notes | No, not its job | – |
| Embryology records + witnessing | Yes, purpose-built | Rarely modelled | No | – |
| Cryo-storage inventory (tank / straw) | Yes | No (pharmacy-style stock) | No | – |
| Donor / gamete traceability | Yes | Varies, often thin | No | – |
| ART Act consent + registry export | Should support, confirm it | Unlikely | No | – |
| Drafts the clinical consult note | No | No | Yes, review and sign | – |
Rows describe what each software category is designed to hold, not a specific vendor’s build. Where a cell says “confirm it,” ask the vendor to demonstrate the export live before you sign, because a claim on a slide is not the same as a working registry file.
How does the ART Act 2021 change the record-keeping requirement?
More than most first-time buyers expect. The Assisted Reproductive Technology (Regulation) Act, 2021 turned fertility record-keeping from good practice into a statutory duty, and the software you pick either helps you meet it or quietly makes it harder.
Three points bear directly on the software choice:
- Registration and the National Registry. ART clinics and banks must register, and the Act sets up the National ART and Surrogacy Registry of India that clinics report into. Your software has to hold cycle, donor, and outcome data in a shape you can export for that reporting, not lock it in a format only the vendor can read.
- The companion Surrogacy Act. The Surrogacy (Regulation) Act, 2021 runs alongside the ART Act with its own registration and record rules. If your clinic touches surrogacy, the record-keeping surface is wider, and the software has to keep those records distinct and auditable.
- Outcome tracking for your own audit. The Act’s record demands mean you will track cycle-to-outcome data anyway. Used well, that same data lets the clinic audit its own process over time. Treat it as an internal quality tool, not a marketing number, and never let a vendor turn your outcome data into a success-rate claim on a brochure.
The clean test to put to any vendor: show me, on a live cycle, exactly the records the National Registry expects, and export them. A tool that cannot do that on demand is a compliance risk you inherit the day an inspector asks.
IVF software pricing in India: what to actually budget for
Here is the honest part the listicles skip: India-native ART and fertility vendors mostly sell demo-first and do not publish a rupee figure, so the price flexes with how hard you negotiate and how many modules you switch on. When a number does surface, it tends to land in the low-to-mid thousands per user a month before the 18% GST, and the embryology or lab module is frequently a separate line.
That last point is where budgets slip. A quote for the “clinic” side can look reasonable until you ask what the embryology records, cryo-inventory, and statutory reporting exports cost, and find they are add-ons. So price the whole stack, not the entry tier. A ₹5,000 per user quote becomes ₹5,900 with GST, and if the lab module doubles it, your real monthly number is nothing like the headline.
Three questions settle most of the ambiguity. First, is the embryology lab module included or extra? Second, does statutory registry export come standard or as a paid feature? Third, what counts as one seat, a clinician, a workstation, or a location? Get all three answered in writing, ex-GST, before you sign. The same “₹X per user” means very different things depending on the answers.
The DPDP Act makes reproductive data your legal responsibility
Reproductive data is about as sensitive as clinical data gets, so it deserves the strictest handling in the building. The DPDP Act 2023 does not create a formal sensitive-data category the way some laws do, but that is not licence to treat fertility records casually. Under the Act the clinic is the data fiduciary, and that role carries duties you cannot hand to the vendor.
Two duties bite hardest here. Purpose limitation means you use donor, recipient, and cycle data only for the treatment purpose the person consented to, and not for anything outside the notice you gave. A vendor quietly mining your patient list for its own ends is a liability that lands on you, not them. Storage limitation means you keep data only as long as the purpose needs. That runs into a wall: ART record-keeping norms expect records held for defined periods. The fix is a written retention policy that reconciles both. Not “keep everything forever.”
Then the physical question: where does the data sit, and how do you get donor and recipient records back if you leave? Cloud software puts some of the most sensitive records a clinic will ever hold on someone else’s servers. Ask where they live, how they are protected, and what the exit looks like. A vendor that cannot answer both crisply is a vendor that makes your DPDP posture worse.
Where does AI documentation fit in a fertility clinic?
In the consult note, and nowhere near the embryology bench. This is the part where an ambient layer earns its place without overreaching, and the boundary matters more here than in most clinics.
A fertility consult still produces a written record: the history, the discussion of options and risks, the plan for this cycle, the counselling that took the bulk of the appointment. Typing that up between emotionally heavy consultations is where a busy day quietly runs long. An ambient documentation layer listens during the visit and drafts that note, which the clinician then reviews, edits, and signs. It does not touch the stimulation chart, the embryology record, the cryo-inventory, or the registry export. Those live in your specialist systems, and they should. The AI does one job: it hands back the consult note as a draft, faster than typing from memory after the patient has left.
A few design points matter for an Indian clinic specifically. Consults happen in braided Hindi and English, so the layer takes code-mixed speech and returns the note in clean clinical English. The visit audio is processed in memory and discarded once the note drafts, so there is no recording sitting on a server, which is the cleaner posture under the DPDP Act given how sensitive fertility conversations are. And the output is always a draft: the clinician reviews and signs, the software never signs for you. Any prescription it suggests is a draft to check, not an order it sends, and any ICD-10 code is a suggestion, not a final coding decision.
That layer is Practice Copilot, our AI bundle for Indian clinics, with the ambient documentation module doing the note-taking. We publish our prices rather than gating them, and we are candid about scope: ABDM integration is on our roadmap, not shipped, and we will not badge a status we do not hold. We do not claim to do embryology witnessing or statutory reporting, because that is not what an AI note-drafter is for. If your prescriptions also eat time, the prescription drafting guide covers where that fits, and the NABH documentation guide is worth a read if accreditation is on your horizon.
The buying advice we would give a friend who runs an ART clinic: choose the core system on the cycle timeline, the embryology records, and the registry export, because those are the parts that are hard to replace and legally load-bearing. Then decide separately whether the consult note is eating your evenings. If it is, add a documentation layer on top rather than rebuilding around it. Book a short demo and watch a real consult turn into a draft note before you commit to anything.
Sources: The ART (Regulation) Act, 2021 and The Surrogacy (Regulation) Act, 2021 (India Code); National ART and Surrogacy Registry (MoHFW); MeitY, DPDP Act 2023; NHA / ABDM portal.